uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics


uniQure N.V. - Ordinary Shares (QURE)

Today's Latest Price: $41.36 USD

0.06 (0.15%)

Updated Aug 10 4:00pm

Add QURE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 344 in Biotech

See all "A" rated Strong Buy stocks

QURE Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for QURE is 0.02 -- better than merely 9.83% of US stocks.
  • QURE's price/sales ratio is 345.69; that's higher than the P/S ratio of 98.55% of US stocks.
  • As for revenue growth, note that QURE's revenue has grown -36.53% over the past 12 months; that beats the revenue growth of only 6% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to uniQure NV, a group of peers worth examining would be OTIC, SNDX, CCXI, CKPT, and SYRS.
  • QURE's SEC filings can be seen here. And to visit uniQure NV's official web site, go to www.uniqure.com.
QURE Daily Price Range
QURE 52-Week Price Range

QURE Stock Price Chart Technical Analysis Charts


QURE Price/Volume Stats

Current price $41.36 52-week high $76.69
Prev. close $41.30 52-week low $36.20
Day low $40.78 Volume 228,300
Day high $41.65 Avg. volume 503,797
50-day MA $50.88 Dividend yield N/A
200-day MA $56.43 Market Cap 1.84B

uniQure N.V. - Ordinary Shares (QURE) Company Bio


uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.





QURE Latest News Stream


Event/Time News Detail
Loading, please wait...

QURE Latest Social Stream


Loading social stream, please wait...

View Full QURE Social Stream

Latest QURE News From Around the Web

Below are the latest news stories about uniQure NV that investors may wish to consider to help them evaluate QURE as an investment opportunity.

A Quick Investment Idea On uniQure

I didn't born to sit in the some ever to cry why i came in this world or cry on my luck no way, i was born to make the impossible possible."― Wahid Bhat Last month uniQure (QURE) announced it has sold global rights to its most advanced compound in...

Bret Jensen on Seeking Alpha | July 30, 2020

UniQure (QURE) Reports Q2 Loss, Lags Revenue Estimates

uniQure (QURE) delivered earnings and revenue surprises of -100.00% and -91.41%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 30, 2020

uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company Progress

~ Entered into Exclusive Global License Agreement with CSL Behring for Development and Commercialization of uniQure’s Gene Therapy Candidate for Hemophilia B ~~ Completed First Patient Dosing in Phase I/II Clinical Trial of AMT-130 in Huntington’s Disease ~LEXINGTON, Mass. and AMSTERDAM, July 30, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the second quarter of 2020 and highlighted recent progress across its business.“The first half of 2020 has been extremely productive for uniQure with significant achievements across our clinical-stage programs,” stated Matt Kapusta, chief executive officer at uniQure. “The initiation of patient do...

Yahoo | July 30, 2020

UniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 27, 2020

Were Hedge Funds Right About Piling Into Uniqure NV (QURE)?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | July 8, 2020

Read More 'QURE' Stories Here

QURE Price Returns

1-mo -10.88%
3-mo -32.25%
6-mo -35.02%
1-year -24.08%
3-year 386.59%
5-year 55.43%
YTD -42.28%
2019 148.65%
2018 47.12%
2017 249.82%
2016 -66.14%
2015 11.68%

Continue Researching QURE

Want to see what other sources are saying about uniQure NV's financials and stock price? Try the links below:

uniQure NV (QURE) Stock Price | Nasdaq
uniQure NV (QURE) Stock Quote, History and News - Yahoo Finance
uniQure NV (QURE) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9047 seconds.